INBISTRA is a consulting firm specialising in preclinical research and early-stage biopharmaceutical companies. We assist start-ups, investors and research centres in selecting targets, therapeutic positioning and asset and corporate valuation.

Our work is based on methodologies designed to reduce subjectivity and anticipate risks. As a boutique consultancy, each project receives direct attention from senior experts, with an independent and actionable approach that drives the scientific, strategic and financial value of each opportunity.